Anavex
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Anavex and other ETFs, options, and stocks.About AVXL
Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome.
CEOChristopher U. Missling
CEOChristopher U. Missling
Employees42
Employees42
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2004
Founded2004
Employees42
Employees42
AVXL Key Statistics
Market cap561.75M
Market cap561.75M
Price-Earnings ratio-11.45
Price-Earnings ratio-11.45
Dividend yield—
Dividend yield—
Average volume1.66M
Average volume1.66M
High today$6.95
High today$6.95
Low today$6.50
Low today$6.50
Open price$6.59
Open price$6.59
Volume1.40M
Volume1.40M
52 Week high$14.44
52 Week high$14.44
52 Week low$6.35
52 Week low$6.35
Stock Snapshot
Anavex(AVXL) stock is priced at $6.54, giving the company a market capitalization of 561.75M. It carries a P/E multiple of -11.45.
As of 2025-11-11, Anavex(AVXL) stock has fluctuated between $6.50 and $6.95. The current price stands at $6.54, placing the stock +0.6% above today's low and -5.9% off the high.
The Anavex(AVXL)'s current trading volume is 1.4M, compared to an average daily volume of 1.66M.
During the past year, Anavex(AVXL) stock moved between $6.35 at its lowest and $14.44 at its peak.
During the past year, Anavex(AVXL) stock moved between $6.35 at its lowest and $14.44 at its peak.
People also own
Based on the portfolios of people who own AVXL. This list is generated using Robinhood data, and it’s not a recommendation.